PubMed:7585505 JSONTXT

Annnotations TAB JSON ListView MergeView

    DisGeNET

    {"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":1023,"end":1026},"obj":"gene:3565"},{"id":"T1","span":{"begin":1114,"end":1128},"obj":"disease:C0149678"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.\nB lymphocytes in the peripheral circulation are maintained in a non-proliferative state. Antigen recognition stimulates limited proliferation, whereas infection with Epstein-Barr virus (EBV) results in continual proliferation and the outgrowth of immortal cell lines. Because it is not clear at which point in cell cycle the peripheral B lymphocytes are arrested, we characterized the expression of several cell cycle-associated genes in quiescent and stimulated cells. We show that the expression of four cell genes, cdc-2, cyclin E, CD23, and cyclin D2, are up-regulated approximately 100-fold as a result of EBV-mediated immortalization. Because these genes play a positive role in cell proliferation, we suggest that this regulatory switch contributes to controlling entry into the cell cycle. Transient stimulation of quiescent B lymphocytes with either a cocktail of anti-CD40, anti-IgM, and IL4, or EBV results in the rapid expression of the same four genes, suggesting that, after infection, EBV exploits the normal program of B-lymphocyte cell cycle activation."}

    jnlpba-st-training

    {"project":"jnlpba-st-training","denotations":[{"id":"T1","span":{"begin":78,"end":101},"obj":"cell_type"},{"id":"T2","span":{"begin":125,"end":138},"obj":"cell_type"},{"id":"T3","span":{"begin":372,"end":391},"obj":"cell_line"},{"id":"T4","span":{"begin":450,"end":474},"obj":"cell_type"},{"id":"T5","span":{"begin":532,"end":559},"obj":"DNA"},{"id":"T6","span":{"begin":563,"end":593},"obj":"cell_type"},{"id":"T7","span":{"begin":631,"end":641},"obj":"DNA"},{"id":"T8","span":{"begin":643,"end":648},"obj":"DNA"},{"id":"T9","span":{"begin":650,"end":658},"obj":"DNA"},{"id":"T10","span":{"begin":660,"end":664},"obj":"DNA"},{"id":"T11","span":{"begin":670,"end":679},"obj":"DNA"},{"id":"T12","span":{"begin":948,"end":971},"obj":"cell_type"},{"id":"T13","span":{"begin":998,"end":1007},"obj":"protein"},{"id":"T14","span":{"begin":1009,"end":1017},"obj":"protein"},{"id":"T15","span":{"begin":1023,"end":1026},"obj":"protein"},{"id":"T16","span":{"begin":1160,"end":1172},"obj":"cell_type"}],"text":"The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.\nB lymphocytes in the peripheral circulation are maintained in a non-proliferative state. Antigen recognition stimulates limited proliferation, whereas infection with Epstein-Barr virus (EBV) results in continual proliferation and the outgrowth of immortal cell lines. Because it is not clear at which point in cell cycle the peripheral B lymphocytes are arrested, we characterized the expression of several cell cycle-associated genes in quiescent and stimulated cells. We show that the expression of four cell genes, cdc-2, cyclin E, CD23, and cyclin D2, are up-regulated approximately 100-fold as a result of EBV-mediated immortalization. Because these genes play a positive role in cell proliferation, we suggest that this regulatory switch contributes to controlling entry into the cell cycle. Transient stimulation of quiescent B lymphocytes with either a cocktail of anti-CD40, anti-IgM, and IL4, or EBV results in the rapid expression of the same four genes, suggesting that, after infection, EBV exploits the normal program of B-lymphocyte cell cycle activation."}

    DisGeNET5_gene_disease

    {"project":"DisGeNET5_gene_disease","denotations":[{"id":"7585505-6#100#103#gene3565","span":{"begin":1023,"end":1026},"obj":"gene3565"},{"id":"7585505-6#191#205#diseaseC0149678","span":{"begin":1114,"end":1128},"obj":"diseaseC0149678"}],"relations":[{"id":"100#103#gene3565191#205#diseaseC0149678","pred":"associated_with","subj":"7585505-6#100#103#gene3565","obj":"7585505-6#191#205#diseaseC0149678"}],"text":"The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.\nB lymphocytes in the peripheral circulation are maintained in a non-proliferative state. Antigen recognition stimulates limited proliferation, whereas infection with Epstein-Barr virus (EBV) results in continual proliferation and the outgrowth of immortal cell lines. Because it is not clear at which point in cell cycle the peripheral B lymphocytes are arrested, we characterized the expression of several cell cycle-associated genes in quiescent and stimulated cells. We show that the expression of four cell genes, cdc-2, cyclin E, CD23, and cyclin D2, are up-regulated approximately 100-fold as a result of EBV-mediated immortalization. Because these genes play a positive role in cell proliferation, we suggest that this regulatory switch contributes to controlling entry into the cell cycle. Transient stimulation of quiescent B lymphocytes with either a cocktail of anti-CD40, anti-IgM, and IL4, or EBV results in the rapid expression of the same four genes, suggesting that, after infection, EBV exploits the normal program of B-lymphocyte cell cycle activation."}

    genia-medco-coref

    {"project":"genia-medco-coref","denotations":[{"id":"C1","span":{"begin":0,"end":40},"obj":"NP"},{"id":"C3","span":{"begin":78,"end":101},"obj":"NP"},{"id":"C4","span":{"begin":105,"end":123},"obj":"NP"},{"id":"C2","span":{"begin":61,"end":123},"obj":"NP"},{"id":"C5","span":{"begin":125,"end":168},"obj":"NP"},{"id":"C7","span":{"begin":291,"end":315},"obj":"NP"},{"id":"C6","span":{"begin":276,"end":315},"obj":"NP"},{"id":"C8","span":{"begin":446,"end":474},"obj":"NP"},{"id":"C9","span":{"begin":626,"end":641},"obj":"NP"},{"id":"C10","span":{"begin":643,"end":679},"obj":"NP"},{"id":"C11","span":{"begin":774,"end":785},"obj":"NP"},{"id":"C12","span":{"begin":846,"end":868},"obj":"NP"},{"id":"C13","span":{"begin":948,"end":971},"obj":"NP"},{"id":"C14","span":{"begin":1031,"end":1034},"obj":"NP"},{"id":"C15","span":{"begin":1070,"end":1089},"obj":"NP"},{"id":"C16","span":{"begin":1114,"end":1123},"obj":"NP"},{"id":"C17","span":{"begin":1125,"end":1128},"obj":"NP"},{"id":"C18","span":{"begin":1138,"end":1194},"obj":"NP"}],"relations":[{"id":"R1","pred":"coref-ident","subj":"C7","obj":"C4"},{"id":"R2","pred":"coref-ident","subj":"C6","obj":"C2"},{"id":"R3","pred":"coref-ident","subj":"C8","obj":"C5"},{"id":"R4","pred":"coref-appos","subj":"C10","obj":"C9"},{"id":"R5","pred":"coref-ident","subj":"C11","obj":"C9"},{"id":"R6","pred":"coref-ident","subj":"C12","obj":"C6"},{"id":"R7","pred":"coref-ident","subj":"C13","obj":"C3"},{"id":"R8","pred":"coref-ident","subj":"C14","obj":"C7"},{"id":"R9","pred":"coref-ident","subj":"C15","obj":"C11"},{"id":"R10","pred":"coref-ident","subj":"C16","obj":"C6"},{"id":"R11","pred":"coref-ident","subj":"C17","obj":"C14"},{"id":"R12","pred":"coref-ident","subj":"C18","obj":"C1"}],"text":"The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.\nB lymphocytes in the peripheral circulation are maintained in a non-proliferative state. Antigen recognition stimulates limited proliferation, whereas infection with Epstein-Barr virus (EBV) results in continual proliferation and the outgrowth of immortal cell lines. Because it is not clear at which point in cell cycle the peripheral B lymphocytes are arrested, we characterized the expression of several cell cycle-associated genes in quiescent and stimulated cells. We show that the expression of four cell genes, cdc-2, cyclin E, CD23, and cyclin D2, are up-regulated approximately 100-fold as a result of EBV-mediated immortalization. Because these genes play a positive role in cell proliferation, we suggest that this regulatory switch contributes to controlling entry into the cell cycle. Transient stimulation of quiescent B lymphocytes with either a cocktail of anti-CD40, anti-IgM, and IL4, or EBV results in the rapid expression of the same four genes, suggesting that, after infection, EBV exploits the normal program of B-lymphocyte cell cycle activation."}

    pubmed-sentences-benchmark

    {"project":"pubmed-sentences-benchmark","denotations":[{"id":"S1","span":{"begin":0,"end":124},"obj":"Sentence"},{"id":"S2","span":{"begin":125,"end":213},"obj":"Sentence"},{"id":"S3","span":{"begin":214,"end":392},"obj":"Sentence"},{"id":"S4","span":{"begin":393,"end":594},"obj":"Sentence"},{"id":"S5","span":{"begin":595,"end":765},"obj":"Sentence"},{"id":"S6","span":{"begin":766,"end":922},"obj":"Sentence"},{"id":"S7","span":{"begin":923,"end":1195},"obj":"Sentence"}],"text":"The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.\nB lymphocytes in the peripheral circulation are maintained in a non-proliferative state. Antigen recognition stimulates limited proliferation, whereas infection with Epstein-Barr virus (EBV) results in continual proliferation and the outgrowth of immortal cell lines. Because it is not clear at which point in cell cycle the peripheral B lymphocytes are arrested, we characterized the expression of several cell cycle-associated genes in quiescent and stimulated cells. We show that the expression of four cell genes, cdc-2, cyclin E, CD23, and cyclin D2, are up-regulated approximately 100-fold as a result of EBV-mediated immortalization. Because these genes play a positive role in cell proliferation, we suggest that this regulatory switch contributes to controlling entry into the cell cycle. Transient stimulation of quiescent B lymphocytes with either a cocktail of anti-CD40, anti-IgM, and IL4, or EBV results in the rapid expression of the same four genes, suggesting that, after infection, EBV exploits the normal program of B-lymphocyte cell cycle activation."}

    GENIAcorpus

    {"project":"GENIAcorpus","denotations":[{"id":"T1","span":{"begin":11,"end":40},"obj":"other_name"},{"id":"T2","span":{"begin":78,"end":101},"obj":"cell_type"},{"id":"T3","span":{"begin":105,"end":123},"obj":"virus"},{"id":"T4","span":{"begin":125,"end":138},"obj":"cell_type"},{"id":"T5","span":{"begin":146,"end":168},"obj":"other_name"},{"id":"T6","span":{"begin":189,"end":212},"obj":"other_name"},{"id":"T7","span":{"begin":291,"end":309},"obj":"virus"},{"id":"T8","span":{"begin":311,"end":314},"obj":"virus"},{"id":"T9","span":{"begin":372,"end":391},"obj":"cell_line"},{"id":"T10","span":{"begin":450,"end":460},"obj":"cell_type"},{"id":"T11","span":{"begin":461,"end":474},"obj":"cell_type"},{"id":"T12","span":{"begin":532,"end":559},"obj":"DNA_family_or_group"},{"id":"T13","span":{"begin":631,"end":641},"obj":"DNA_family_or_group"},{"id":"T14","span":{"begin":643,"end":648},"obj":"DNA_domain_or_region"},{"id":"T15","span":{"begin":650,"end":658},"obj":"DNA_domain_or_region"},{"id":"T16","span":{"begin":660,"end":664},"obj":"DNA_domain_or_region"},{"id":"T17","span":{"begin":670,"end":679},"obj":"DNA_domain_or_region"},{"id":"T18","span":{"begin":736,"end":739},"obj":"virus"},{"id":"T19","span":{"begin":851,"end":868},"obj":"other_name"},{"id":"T20","span":{"begin":911,"end":921},"obj":"other_name"},{"id":"T21","span":{"begin":923,"end":944},"obj":"other_name"},{"id":"T22","span":{"begin":948,"end":957},"obj":"cell_type"},{"id":"T23","span":{"begin":958,"end":971},"obj":"cell_type"},{"id":"T24","span":{"begin":998,"end":1007},"obj":"protein_family_or_group"},{"id":"T25","span":{"begin":1009,"end":1017},"obj":"protein_family_or_group"},{"id":"T26","span":{"begin":1023,"end":1026},"obj":"protein_molecule"},{"id":"T27","span":{"begin":1031,"end":1034},"obj":"virus"},{"id":"T28","span":{"begin":1050,"end":1066},"obj":"other_name"},{"id":"T29","span":{"begin":1125,"end":1128},"obj":"virus"},{"id":"T30","span":{"begin":1160,"end":1172},"obj":"cell_type"}],"text":"The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.\nB lymphocytes in the peripheral circulation are maintained in a non-proliferative state. Antigen recognition stimulates limited proliferation, whereas infection with Epstein-Barr virus (EBV) results in continual proliferation and the outgrowth of immortal cell lines. Because it is not clear at which point in cell cycle the peripheral B lymphocytes are arrested, we characterized the expression of several cell cycle-associated genes in quiescent and stimulated cells. We show that the expression of four cell genes, cdc-2, cyclin E, CD23, and cyclin D2, are up-regulated approximately 100-fold as a result of EBV-mediated immortalization. Because these genes play a positive role in cell proliferation, we suggest that this regulatory switch contributes to controlling entry into the cell cycle. Transient stimulation of quiescent B lymphocytes with either a cocktail of anti-CD40, anti-IgM, and IL4, or EBV results in the rapid expression of the same four genes, suggesting that, after infection, EBV exploits the normal program of B-lymphocyte cell cycle activation."}